ISSN 1662-4009 (online)

ey0019.5-14 | Translational highlights | ESPEYB19

5.14. Fibrillin-1 deficiency in the outer perichondrium causes longitudinal bone overgrowth in mice with Marfan syndrome

L Sedes , E Wondimu , B Crockett , J Hansen , A Cantalupo , K Asano , R Iyengar , D.B Rifkin , S Smaldone , F Ramirez

Hum Mol Genet ddac107 (2022)Abstract: https://pubmed.ncbi.nlm.nih.gov/35567544/In Brief: Disproportionate tall stature represents a hallmark feature of Marfan syndrome, although specific mechanisms underlying linear bone overgrowth are unclear. This study used an ex vivo model system to identify dysregulation of TGFβ-binding proteins in the outer perichondrium as causative for the bon...

ey0019.10-10 | Advances in clinical practice | ESPEYB19

10.10. Telemedicine and COVID-19 pandemic: the perfect storm to mark a change in diabetes care results from a world-wide cross-sectional web-based survey

E Giani , K Dovc , Santos TJ Dos , A Chobot , K Braune , R Cardona-Hernandez , Beaufort C De , A Scaramuzza

ISPAD Jenious Group. Pediatr Diabetes. 2021;22:1115-1119. https://pubmed.ncbi.nlm.nih.gov/34741569/Brief Summary: This cross-sectional survey describes healthcare professionals’ (HCPs) experiences of telemedicine use in diabetes centers across the world, along with the adaptations and challenges associated with its implementation.This is one out of several public...

ey0017.4-6 | Clinical Trials | ESPEYB17

4.6. Once-weekly somapacitan vs daily GH in children with GH deficiency: results from a randomized phase 2 trial

L Savendahl , T Battelino , M Brod , MH Rasmussen , R Horikawa , RV Juul , P REAL 3 study group Saenger

To read the full abstract: J Clin Endocrinol Metab ;105(4):e1847–e1861.The REAL 3 multicenter randomized, controlled, double-blind phase 2 study evaluated the efficacy and safety of different doses of once-weekly Somapacitan, compared to conventional once-daily GH in 59 prepubertal GHD children. The treatment period lasted 26 weeks and an additional extension to 52 weeks. At week 26, height velocity (HV) was 7.8, 10.9 and 13.1 cm/year, resp...

ey0017.4-10 | New perspectives | ESPEYB17

4.10. IGF-I in cord blood is predictive of final height in monozygotic twins with intratwin birth weight differences

C Kasner , S Schulte , F Schreiner , R Fimmers , B Stoffel-Wagner , P Bartmann , J Woelfle , B Gohlke

To read the full abstract: Clin Endocrinol (Oxf) 2020 May 13. doi: 10.1111/cen.14221. Online ahead of print.Children born either small for gestational age (SGA) or preterm usually do not achieve a final height (FH) in the mid-parental target height (MPTH) range, despite showing catch-up growth in the first years of life (1). The influence of intrauterine metabolic and hormonal factors has been p...

ey0017.5-15 | Advances in Skeletal Biology | ESPEYB17

5.15. A simple method based on confocal microscopy and thick sections recognizes seven subphases in growth plate chondrocytes

A Fernandez-Iglesias , R Fuente , H Gil-Pena , L Alonso-Duran , M Garcia-Bengoa , F et al. Santos

To read the full abstract: Sci Rep 2020;10:6935.In brief: A well-defined and optimized protocol using confocal microscopy allowed novel insight into growth plate chondrocyte differentiation by quantitative analysis of cellular characteristics of murine growth plate samples.Commentary: The growth plate is a complex tissue with a unique morphology char...

ey0017.6-20 | Transgender Medicine: Treatment and Cardiovascular Effects | ESPEYB17

6.20. Hormonal treatment and cardiovascular risk profile in transgender adolescents

M Klaver , R de Mutsert , M van der Loos , CM Wiepjes , JWR Twisk , M den Heijer , J Rotteveel , DT Klink

To read the full abstract: Pediatrics. 2020, Mar; 145. doi: https://pediatrics.aappublications.org/content/pediatrics/145/3/e20190741.full.pdfCardiovascular health of transgender people was a hot topic in the transgender literature last year, triggered by previous findings that these individuals could have elevated risks for cardiovascular diseases b...

ey0017.9-6 | Fertility-Related Issues | ESPEYB17

9.6. Assessment of ovarian function in adolescents and young adults after childhood cancer treatment-How accurate are young adult/parent proxy-reported outcomes?

SA George , R Williamson Lewis , L McKenzie , B Cherven , BC Patterson , KE Effinger , AC Mertens , LR Meacham

To read the full abstract: Pediatr Blood Cancer. 2019;66(12):e27981. sgeorg4@emory.eduThis cross-sectional study tested the concordance between young adult (or parent proxy)-reported premature ovarian insufficiency (POI) and biochemical evidence of POI, defined as FSH ≥40 mIU/ml, in 182 childhood cancer survivors (CCS) who had received gonadotoxic therapy. Reported POI was defined as the survivor taki...

ey0017.9-12 | Childhood Cancer, Radiation Therapy and Thyroid Disease | ESPEYB17

9.12. Ultrasound is superior to palpation for thyroid cancer detection in high-risk childhood cancer and BMT survivors

J Hess , K Schafernak , D Newbern , T Vern-Gross , J Foote , D Van Tassel , R Jamshidi , A Walsh

To read the full abstract: Support Care Cancer. 2020 Feb 11. Epub ahead of print. hess2@phoenixchildrens.comThe development of a second neoplasia is a major concern during the follow-up of childhood cancer survivors (CCS). Secondary cancers account for nearly 50% of non-relapse mortality at 5 years. Thyroid tumours represent 10-20% of subsequent neoplasia cases, due to the high sensitivity of the g...

ey0017.9-14 | Cancer Treatment and Bone Health | ESPEYB17

9.14. High impact physical activity and bone health of lower extremities in childhood cancer survivors: A cross-sectional study of SURfit

SJ Zurcher , R Jung , S Monnerat , C Schindera , P Eser , C Meier , CS Rueegg , NX von der Weid , S Kriemler

To read the full abstract: Int J Cancer. 2020 Mar 13. doi: 10.1002/ijc.32963. Epub ahead of print. susi.kriemlerwiget@uzh.chChildhood cancer survivors (CCS) can experience impaired bone health as a consequence of the disease itself, the specific treatments and/or associated chronic conditions. This cross-sectional study analyses baseline data from th...

ey0017.11-8 | Body Weight Regulation and Insulin Sensitivity | ESPEYB17

11.8. Brain insulin sensitivity is linked to adiposity and body fat distribution

S Kullmann , V Valenta , R Wagner , O Tschritter , J Machann , HU Haring , H Preissl , A Fritsche , M Heni

To read the full abstract: Nat Commun. 2020;11(1):1841. Published 2020 Apr 15. doi: https://pubmed.ncbi.nlm.nih.gov/32296068/This study by Kullmann et al. investigated the impact of brain insulin resistance on medium and long-term changes in body weight and body fat in adults at high risk for T2DM, undergoing a 24-months lifestyle intervention program (n =28 at the 24-mont...